Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VAXCYTE, INC.

(PCVX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about VAXCYTE, INC.
01/13AFTER HOURS WATCH LIST SCORECARD : Kbh, pcvx, estc
MT
01/13Health Care Stocks Losing More Ground as Biotechs Sputter in Late Trade
MT
01/13Health Care Stocks Fading Thursday as Biotechs Stumble
MT
01/13Health Care Stocks Mixed Pre-Bell Thursday
MT
01/13Vaxcyte Prices Offering of Common Shares, Warrants; Expects $100 Million Gross Proceeds
MT
01/13Vaxcyte Announces Pricing of $100 Million Public Offering
GL
01/13Vaxcyte Announces Pricing of $100 Million Public Offering
GL
01/12MT NEWSWIRES AFTER HOURS WATCH LIST : Kbh, pcvx, estc
MT
01/12Vaxcyte Launches Public Offering of Shares, Warrants; Stock Plunge After-Hours
MT
01/12Vaxcyte Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
AQ
01/06VAXCYTE : Investor Presentation January 2022
PU
01/06Vaxcyte Secures US FDA Approval of Investigational New Drug Application for Invasive Pn..
MT
01/06Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for ..
AQ
01/06Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for ..
CI
2021INSIDER SELL : Vaxcyte
MT
2021Vaxcyte Shares Rise After Jefferies Resumes Coverage at Buy
MT
2021INSIDER SELL : Vaxcyte
MT
2021Vaxcyte to Present at Upcoming Investor Conferences
GL
2021Vaxcyte Investor Presentation November 2021
PU
2021Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update - For..
PU
2021Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update
GL
2021Vaxcyte, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
CI
2021Vaxcyte Appoints Carlos Paya and Michael Kamarck to Its Board of Directors
AQ
2021Vaxcyte, Inc. Announces Board Changes
CI
2021INSIDER SELL : Vaxcyte
MT
2021VAXCYTE : to Present at Guggenheim 2nd Annual Vaccine and Infectious Disease Conference
AQ
2021VAXCYTE : to Present at 2021 Cantor Virtual Global Healthcare Conference
AQ
2021VAXCYTE : Investor Presentation September 2021
PU
2021Vaxcyte Appoints Annie Drapeau and Teri Loxam to Its Board of Directors
GL
2021Vaxcyte, Inc. Announces Board Changes
CI
2021VAXCYTE : Investor Presentation August 2021
PU
2021VAXCYTE : Reports Second Quarter 2021 Financial Results and Provides Business Update (Form..
PU
2021VAXCYTE : Reports Second Quarter 2021 Financial Results and Provides Business Update
AQ
2021Vaxcyte, Inc. Announces Consolidated Earnings Results for the Second Quarter and Six Mo..
CI
2021VAXCYTE : Announces Expanded CARB-X Award to Advance Development of VAX-A1, a Vaccine to P..
AQ
2021VAXCYTE, INC.(NASDAQGS : PCVX) added to Russell 3000E Growth Index
CI
2021VAXCYTE, INC.(NASDAQGS : PCVX) added to Russell Microcap Growth Index
CI
2021VAXCYTE, INC.(NASDAQGS : PCVX) added to Russell 3000E Index
CI
2021VAXCYTE, INC.(NASDAQGS : PCVX) added to Russell 3000E Value Index
CI
2021VAXCYTE, INC.(NASDAQGS : PCVX) added to Russell Microcap Value Index
CI
2021VAXCYTE, INC.(NASDAQGS : PCVX) added to Russell Microcap Index
CI
2021Vaxcyte to Present at the Jefferies Virtual Healthcare Conference
GL
2021General Atlantic-backed Centessa targets $1.7 bln valuation in U.S. IPO
RE
2021VAXCYTE : Investor Presentation May 2021
PU
2021Vaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update
GL
2021Vaxcyte, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter End..
CI
2021VAXCYTE : Reports First Quarter 2021 Financial Results and Provides Business Update (Form ..
PU
2021VAXCYTE : Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for..
AQ
2021Vaxcyte, Inc. Announces Publication of Preclinical Data Supporting the Potential of VAX..
CI
2021Vaxcyte to Present at BofA Securities 2021 Health Care Conference
GL
2021Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference
GL
2021VAXCYTE : Q4 Loss Narrows, Operating Expenses Rise
MT
2021VAXCYTE : Investor Presentation March 2021
PU
2021Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Busine..
GL
2021Vaxcyte, Inc. Announces Consolidated Financial Results for the Quarter and Year Ended D..
CI
2021GLAXOSMITHKLINE : Former U.S. govt vaccine chief exits two drug developers after GSK haras..
RE
2021Vaxcyte, Inc. Announces Resignation of Moncef Slaoui from the Board
CI
2021GLAXOSMITHKLINE : Slaoui Fired From Startup's Board Over Sexual-Harassment Allegations -- ..
DJ
2021GLAXOSMITHKLINE : Board Fires Galvani Bioelectronics Chairman Moncef Slaoui Amid Sexual Ha..
MT
2021GLAXOSMITHKLINE : Fires Moncef Slaoui as Chair of Galvani Bioelectronics Board of Director..
MT
2021Health Care Down Amid Defensive Bias -- Health Care Roundup
DJ
2021GLAXOSMITHKLINE : Slaoui Fired From Startup's Board Over Sexual Harassment Allegations
DJ
2021GLAXOSMITHKLINE : Fires Chairman Of Galvani Unit Over Sexual Harassment Allegations
MT
2021GlaxoSmithKline Fires Moncef Slaoui Over Alleged Sexual Harassment
DJ
2021Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
GL
2021Vaxcyte, Inc. Enters Lease Agreement with ARE-San Francisco No. 63, LLC
CI
2021Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential..
GL
2021Vaxcyte, Inc. Announces Publication of Preclinical Proof-of-Concept Data Supporting Pot..
CI
2020VAXCYTE : Names Andrew Guggenhime as President
MT
2020Vaxcyte, Inc. Announces Executive Changes
CI
2020Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer
GL
2020VAXCYTE, INC.(NASDAQGS : PCVX) added to S&P Biotechnology Select Industry Index
CI
2020VAXCYTE, INC.(NASDAQGS : PCVX) added to NASDAQ Biotechnology Index
CI
2020VAXCYTE, INC.(NASDAQGS : PCVX) added to S&P Global BMI Index
CI
2020Certain Common Stock of Vaxcyte, Inc. are subject to a Lock-Up Agreement Ending on 9-DE..
CI
1  2Next
Upcoming event on VAXCYTE, INC.
03/28/22